Skip to main content
Caplight Logo









DeepCyto

DeepCyto

Private
SuzhouHealthcare & Life Scienceshttp://deepcyto.cn/

Last Round

Series B

Nov 17, 2022

Est. Valuation

$48.5M

Total Funding Raised

$17.2M

Company Overview

DeepCyto is a medical technology company that provides AI-powered medical diagnosis and healthcare data analysis solutions for blood diseases.

Sector

Healthcare & Life Sciences

Verticals

Medical Imaging, Medical Devices, Medical AI, Biotech Equipment

Business Model

B2B

Customer Profile

Hardware Sales, Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

medical AIdigital pathologyhematology analyzerAI diagnosticsflow cytometrycell imagingmedical imagingcytologylab automationpathology AIclinical decision supportmachine visionSaaSsmart lab

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

DeepCyto Comparables

Compare DeepCyto with similar companies based on industry and business-model similarity.

DeepCyto comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Hangzhou Zhiwei Information Technology Co., Ltd.
84%
SigTuple
80%
Scopio Labs
80%

DeepCyto Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BNov 17, 2022
Series ANov 1, 2021
Series ANov 19, 2020
SeedMay 28, 2018

DeepCyto Investors

Notable investors and investment history

DeepCyto investors
InvestorRounds
Breyer CapitalSeed
Fusion FundSeries B, Seed, Series A
Nina CapitalSeries A
Bencao CapitalSeries A
ZhenFundSeed
Baidu VenturesSeed
Northern Light Venture CapitalSeries A, Pre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 17, 2022

    Led by Primavera Venture Partners and Eastern Bell Capital.

  • Nov 1, 2021

    Closed Series A at $48.5M post-money valuation.

DeepCyto Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

DeepCyto Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about DeepCyto's valuation, stock price, and market status.

Firmographic Details

HeadquartersSuzhou
Year Founded2018
Last FundingNov 17, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?